57645-60-0 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(2-Chlorobenzyl)piperidin-4-amine dihydrochloride is used as a building block for the synthesis of pharmaceutical drugs, particularly those aimed at treating nervous system disorders and requiring pharmacological interventions. Its structural properties make it a promising candidate for the development of novel therapeutic agents.
Used in Antipsychotic and Analgesic Drug Development:
In the field of psychopharmacology, 1-(2-Chlorobenzyl)piperidin-4-amine dihydrochloride has demonstrated activity as a potential antipsychotic and analgesic agent. This makes it a valuable compound for further drug development and research, with the potential to contribute to the creation of new medications for the treatment of various psychiatric and pain-related conditions.
Used in the Synthesis of Nervous System Targeting Drugs:
1-(2-Chlorobenzyl)piperidin-4-amine dihydrochloride is used as a key component in the synthesis of drugs that target the nervous system. Its unique structure allows for the development of medications that can potentially address a range of neurological and psychiatric disorders, making it an important compound in the ongoing search for effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 57645-60-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,6,4 and 5 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57645-60:
(7*5)+(6*7)+(5*6)+(4*4)+(3*5)+(2*6)+(1*0)=150
150 % 10 = 0
So 57645-60-0 is a valid CAS Registry Number.
57645-60-0Relevant academic research and scientific papers
Aromatic amides of heterocyclic compounds and therapeutic compositions containing same
-
, (2008/06/13)
The invention relates to aromatic amides N-substituted by heterocyclic groups. More particularly, the invention relates to substituted benzoic acid amides of 1-arylalkylamino or aminoalkyl-N-heterocyclic rings and to pharmaceutical compositions thereof, which have the ability to antagonize the effects of dopamine or dopaminergic agents of endogenous or exogenous origin and which may be used for the treatment of nausea and vomiting resulting from gastrointestinal disorders, congestive heart failure, post operative conditions, etc., other gastrointestinal disorders such as dyspepsia, flatulence, bile regurgitations, hiatus hernia, peptic ulcer, reflux aerophagitis, gastritis, duodenitis, and cholethiasis, and a variety of conditions affecting the central nervous system such as acute and chronic psychoses, maniacal psychosis, schizophrenias, serious disturbances of behavior and non-melancholic depressive state and migraine.
